Evaluate the Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia
Clinical trial NCT06009393 · COMPLETED
Trial details
- NCT number
- NCT06009393
- Sponsor
- Beijing Suncadia Pharmaceuticals Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-22
- Primary completion
- 2024-06-29
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.